Trinity Biotech (TRIB) Return on Sales (2009 - 2024)

Trinity Biotech has disclosed Return on Sales across 16 years of filings, most recently posting 0.01% for Q4 2024.

• Return on Sales for Q4 2024 came in at 0.01%, down 1.0% year-over-year; the trailing twelve-month figure through Dec 2024 was 0.01% (changed 0.0% YoY), and the FY2025 annual result was 0.01%, down 1.0% from the prior year.
• Return on Sales came in at 0.01% for Q4 2024 at Trinity Biotech, down from 0.0% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.0% in Q3 2020 to a low of 0.01% in Q2 2023.
• The 5-year median for Return on Sales is 0.0% (2024), against an average of 0.0%.
• Across the five-year window, Return on Sales fell 1 bps in 2022 and grew 1 bps in 2024, its largest moves.
• Trinity Biotech's Return on Sales stood at 0.0% in 2020, then sank by 165 bps to 0.0% in 2021, then tumbled by 255 bps to 0.01% in 2022, then surged by 36 bps to 0.0% in 2023, then plunged by 143 bps to 0.01% in 2024.
• The last three Return on Sales figures came in at 0.01% (Q4 2024), 0.0% (Q3 2024), and 0.0% (Q2 2024), per Business Quant data.